(Q44512125)

3 December 2017

title

Cardiovascular risk factors and estimated risk for CAD in a randomized trial comparing calcineurin inhibitors in renal transplantation (English)

1 reference

3 December 2017

main subject

randomized experiment

1 reference

inferred from title

author

Christian Hengstenberg

5

object named as

Christian Hengstenberg

1 reference

3 December 2017

Bernhard K Krämer

1

1 reference

3 December 2017

Carl Zülke

2

1 reference

3 December 2017

Martin C Kammerl

3

1 reference

3 December 2017

Christian Schmidt

4

1 reference

3 December 2017

Michael Fischereder

6

1 reference

3 December 2017

Jörg Marienhagen

7

1 reference

3 December 2017

European Tacrolimus vs. Cyclosporine Microemulsion Renal Transplantation Study Group

8

1 reference

3 December 2017

language of work or name

English

0 references

publication date

1 August 2003

1 reference

American Journal of Transplantation

3 December 2017

published in

1 reference

3 December 2017

volume

3

1 reference

3 December 2017

issue

8

1 reference

3 December 2017

page(s)

982-987

1 reference

Tacrolimus (FK 506) in kidney transplantation: three-year survival results of the US multicenter, randomized, comparative trial. FK 506 Kidney Transplant Study Group

3 December 2017

uses

randomized experiment

0 references

cites work

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-6143.2003.00156.X

Improvement of nephrotoxicity, hypertension, and lipid metabolism after conversion of kidney transplant recipients from cyclosporine to tacrolimus

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-6143.2003.00156.X

Lipoprotein patterns in renal transplant patients: a comparison between FK 506 and cyclosporine A patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-6143.2003.00156.X

Calcineurin-inhibitors in renal transplantation. Too precious to be abandoned

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-6143.2003.00156.X

Efficacy and safety of tacrolimus compared with ciclosporin microemulsion in renal transplantation: a randomised multicentre study

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-6143.2003.00156.X

Prediction of Coronary Heart Disease Using Risk Factor Categories

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-6143.2003.00156.X

Multicenter randomized trial comparing tacrolimus (FK506) and cyclosporine in the prevention of renal allograft rejection: a report of the European Tacrolimus Multicenter Renal Study Group

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-6143.2003.00156.X

Premature cardiovascular disease in chronic renal failure

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-6143.2003.00156.X

Association of chronic kidney graft failure with recipient blood pressure. Collaborative Transplant Study

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-6143.2003.00156.X

Patient survival after renal transplantation: I. The impact of dialysis pre-transplant

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-6143.2003.00156.X

Cyclosporine microemulsion increases drug exposure and reduces acute rejection without incremental toxicity in de novo renal transplantation. International Sandimmun Neoral Study Group

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-6143.2003.00156.X

Controlling the epidemic of cardiovascular disease in chronic renal disease: what do we know? What do we need to learn? Where do we go from here? National Kidney Foundation Task Force on Cardiovascular Disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-6143.2003.00156.X

7 January 2021

Cholesterol as an independent predictor of outcome after renal transplantation

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-6143.2003.00156.X

7 January 2021

Analysis of serial measurements in medical research

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-6143.2003.00156.X

7 January 2021

The safety and tolerability of cyclosporine emulsion versus cyclosporine in a randomized, double-blind comparison in primary renal allograft recipients. The Neoral Study Group

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-6143.2003.00156.X

7 January 2021

10.1034/J.1600-6143.2003.00156.X

Identifiers

DOI

1 reference

3 December 2017

1 reference